Hikma Outlines Strategy For Coping With COVID-19 Demand
US Propofol Launch Addresses Shortage Amid Higher Injectables Demand Overall
As Hikma launches propofol vials in three presentations in the US to address a local shortage, CEO Siggi Olafsson explains how the company is more broadly keeping on top of the higher demand generated by the coronavirus pandemic.
